文献速递眼底病与葡萄膜炎

视网膜液体与厚度作为新生血管性年龄相关性黄斑变性疾病活动度指标

RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
PubMed 文献 · Retina · 2021-01-01

本文综述视网膜液体与厚度作为新生血管性年龄相关性黄斑变性疾病活动度解剖指标的价值。视网膜厚度变化与视力变化相关,且不同液体分区预后价值不同:视网膜内液体与较差视力相关,视网膜下液体与较好视力相关。视网膜液体和厚度有助于在临床试验和临床实践中选择给药间隔。

要点

  • 视网膜厚度变化与视力变化相关,厚度变异可能预测视力结局。
  • 视网膜内液体与较差视力相关,视网膜下液体与较好视力相关。
  • 视网膜液体和厚度用于选择临床试验和临床实践中的给药间隔。

核心结论

  • 视网膜厚度和视网膜液体是新生血管性年龄相关性黄斑变性常用的疾病活动度解剖指标。
  • 需要进一步研究以充分阐明解剖特征与视力结局之间的关系。

研究设计与样本

  • 本文为文献综述,对疾病活动度的解剖指标进行了回顾。

主要发现

  • 视网膜厚度变化与视力变化相关,厚度变异可能预测视力结局。
  • 视网膜内液体的存在与较差视力相关,视网膜下液体的存在与较好视力相关。
  • 不同液体分区可能具有不同的预后价值。

临床怎么用

  • 视网膜液体和厚度可用于在临床实践中选择给药间隔时长。
  • 治疗目标包括通过使视网膜干燥来改善或维持视力。

局限性

  • 需要进一步研究以充分阐明解剖特征与视力结局之间的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Retinal fluid and thickness are important anatomical features of disease activity in neovascular age-related macular degeneration, as evidenced by clinical trials that have used these features for inclusion criteria, retreatment criteria, and outcome measures of the efficacy of intravitreal injections of anti-vascular endothelial growth factor agents. METHODS: A literature review of anatomical measures of disease activity was conducted. RESULTS: Treatment goals for neovascular age-related macular degeneration include improving/maintaining vision by drying the retina, and several analyses have evaluated the relationship between visual function and anatomy. The change in retinal thickness has been found to correlate with the change in the visual acuity, and variation in retinal thickness may predict visual acuity outcomes. In addition, specific fluid compartments may have different prognostic values. For example, the presence of intraretinal fluid has been associated with poorer visual acuity, whereas the presence of subretinal fluid has been associated with better visual acuity. Retinal fluid and thickness are important for selecting dosing interval durations in clinical trials and clinical practice. CONCLUSION: Retinal thickness and retinal fluid are common anatomical measures of disease activity in neovascular age-related macular degeneration. Further research is required to fully elucidate the relationship between anatomical features and visual outcomes in neovascular age-related macular degeneration.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Kaiser PK, Wykoff CC, Singh RP, et al. RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 2021. PMID: 33949342. doi:10.1097/IAE.0000000000003194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。